Heartbeat: delayed and inadequate treatment of acute coronary syndromes during the COVID-19 pandemic
暂无分享,去创建一个
[1] R. Mahajan,et al. Cardiac oxidative stress: a potential tool for risk stratification in cardiac sarcoidosis , 2022, Heart.
[2] M. Yano,et al. Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis , 2022, Heart.
[3] C. Templin,et al. The STEMI phenomenon during the COVID-19 pandemic: what is beneath the tip of the iceberg? , 2022, Heart.
[4] H. Suryapranata,et al. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction , 2021, Heart.
[5] G. Nickenig,et al. Transcatheter tricuspid intervention: ready for primetime? , 2021, Heart.
[6] A. Barac,et al. Implications of cancer prior to and after heart transplantation , 2021, Heart.
[7] I. V. Van Gelder,et al. Update on management of atrial fibrillation in heart failure: a focus on ablation , 2021, Heart.
[8] J. Grunewald,et al. Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden , 2021, Heart.